Silenced ANP32A inhibits the growth, invasion and migration of colorectal cancer in vitro via the inactivation of AKT pathway.
10.12122/j.issn.1673-4254.2023.01.07
- Author:
Hong Fang DING
1
;
Xiao Juan LI
2
;
Lu Wei ZHOU
2
;
Zhi CUI
1
;
Hai De MENG
3
;
Juan WANG
1
Author Information
1. Faculty of Basic Medical Sciences, of Guilin Medical College, Guilin 541199, China.
2. School of Pharmacy, of Guilin Medical College, Guilin 541199, China.
3. School of Intelligent Medicine and Biotechnology, of Guilin Medical College, Guilin 541199, China.
- Publication Type:Journal Article
- Keywords:
AKT;
ANP32A;
colon cancer;
invasion;
migration
- MeSH:
Humans;
Proto-Oncogene Proteins c-akt;
Cell Proliferation;
Blotting, Western;
Cell Movement;
Colonic Neoplasms;
Membrane Proteins;
RNA-Binding Proteins/genetics*;
Nuclear Proteins
- From:
Journal of Southern Medical University
2023;43(1):52-59
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVE:To investigate the effect of ANP32A silencing on invasion and migration of colon cancer cells and the influence of the activity of AKT signaling pathway on this effect.
METHODS:Colorectal cancer HCT116 and SW480 were transfected with a small interfering RNA targeting ANP32A via a lentiviral vector. At 24, 48 and 72 h after the transfection, the changes in cell proliferation and AKT activity in the cells were detected using MTT assay and Western blotting, respectively. HCT116 and SW480 cells were treated with the AKT agonist SC79 or its inhibitor MK2206 for 24, 48, 72 and 96 h, and the changes in cell migration and invasion ability were analyzed using Transwell chamber assay and cell proliferation was assessed using MTT assay. The effects of SC79 and MK2206 on migration and invasion abilities of HCT116 and SW480 cells with or without ANP32A silencing were examined using wound healing and Transwell chamber assays, and the changes in the expression of metadherin (MTDH), a factor associated with cells invasion and migration, was detected with Western blotting.
RESULTS:Lentivirus-mediated ANP32A silencing significantly down-regulated the activity of AKT and inhibited the proliferation of both HCT116 and SW480 cells (P < 0.01). The application of AKT inhibitor MK2206 obviously inhibited the proliferation, invasion and migration of the colorectal cancer cells (P < 0.05), while the AKT agonist SC79 significantly promoted the invasion and migration of the cells (P < 0.01). In HCT116 and SW480 cells with ANP32A silencing, treatment with MK2206 strongly enhanced the inhibitory effects of ANP32A silencing on cell invasion and migration (P < 0.05) and the expression of MTDH, while SC79 partially reversed these inhibitory effects (P < 0.01).
CONCLUSION:ANP32A silencing inhibits invasion and migration of colorectal cancer cells possibly by inhibiting the activation of the AKT signaling pathway.
